HIV / AIDS

Summary

This report presents the key achievements of all actors in HIV/AIDS, STIs, and Viral Hepatitis response, from July 2023 to June 2024, as referred to as the reporting period. It covers essential areas of interventions in the fight against HIV/AIDS, STIs, and Viral Hepatitis, namely prevention, care and treatment, social impact mitigation, health system strengthening, financing HIV national response, and strategic information. The national program prioritizes targeted testing. This year, the number of HIV tests conducted decreased from 2,283,301 to 2,072,366 tests. A high decrease was reported in HIV testing services (HTS). The overall HIV testing yield remained at 0.7%. The highest HIV testing yield of 4.1% was recorded among elicited partners of index cases who were reached and tested through partner notification services. Rwanda embarked on the plan for the elimination of mother-to-child HIV transmission. From July 2023 to June 2024, 344,746 pregnant women were tested for HIV out of those who attended ANC visits. Of these, 1,151 pregnant women tested positive for HIV, translating into a positivity rate of 0.3%. Overall, 99.8% of pregnant women living with HIV received ART to reduce mother to child HIV transmission during the fiscal year 2023-2024. Rwanda is implementing oral Pre-exposure prophylaxis (PrEP) among key populations and sero-discordant couples as part of the HIV prevention package. By June 2024, the number of female sex workers and men who have sex with men receiving PrEP had gradually increased to 12,187. In addition, during this fiscal year, 355,728 men were circumcised. During this reporting period, people who were diagnosed with HIV were linked to HIV care and treatment services. By the end of June 2024, a total number of 222,604 were on ART and the overall retention rate was 94%. The overall viral load suppression was at 97%.

Download document